Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions
Sponsor
Boehringer Ingelheim (Industry)
Overall Status
Completed
CT.gov ID
NCT02184052
Collaborator
(none)
121
Study Details
Study Description
Brief Summary
Study to determine the safety and efficacy of Mobic® ampoules in the initiation of treatment of painful exacerbations of osteoarthritis, rheumatoid arthritis and other similar painful inflammatory conditions.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
Study Design
Study Type:
Observational
Actual Enrollment
:
121 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Meloxicam (MOBIC®) Ampoule Post Marketing Surveillance Study
Study Start Date
:
Jul 1, 2003
Actual Primary Completion Date
:
Mar 1, 2005
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Meloxicam
|
Drug: Meloxicam
7.5 mg or 15 mg
|
Outcome Measures
Primary Outcome Measures
- Overall assessment of degree of pain on a 3-point scale [up to 3 days]
Secondary Outcome Measures
- Number of patients with adverse events [up to 3 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Painful acute exacerbations of inflammatory rheumatism (rheumatoid arthritis and ankylosing spondylitis), painful acute exacerbations of osteoarthritis and other similar conditions requiring acute treatment with an anti-inflammatory drug
Exclusion Criteria:
- none
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Boehringer Ingelheim
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT02184052
Other Study ID Numbers:
- 107.267
First Posted:
Jul 9, 2014
Last Update Posted:
Jul 9, 2014
Last Verified:
Jul 1, 2014